Pharmacokinetic-Pharmacodynamic Analysis of Lopinavir-Ritonavir in Combination with Efavirenz and Two Nucleoside Reverse Transcriptase Inhibitors in Extensively Pretreated Human Immunodeficiency Virus-Infected Patients

The steady-state pharmacokinetics and pharmacodynamics of two oral doses of lopinavir-ritonavir (lopinavir/r; 400/100 and 533/133 mg) twice daily (BID) when dosed in combination with efavirenz, plus two nucleoside reverse transcriptase inhibitors, were assessed in a phase II, open-label, randomized,...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Hsu, Ann, Isaacson, Jeffrey, Brun, Scott, Bernstein, Barry, Lam, Wayne, Bertz, Richard, Foit, Cheryl, Rynkiewicz, Karen, Richards, Bruce, King, Martin, Rode, Richard, Kempf, Dale J., Granneman, G. Richard, Sun, Eugene
格式: Artigo
語言:Inglês
出版: American Society for Microbiology 2003
主題:
Antiviral Agents
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC148953/
https://ncbi.nlm.nih.gov/pubmed/12499212
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.47.1.350-359.2003
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍